Knopp Biosciences and Population Health Partners Create Areteia Therapeutics, New Clinical-Stage Asthma Company, with $350 Million in Funding

PITTSBURGH, Pa. & SHORT HILLS, N.J.–(BUSINESS WIRE)–Jul 12, 2022– Areteia Therapeutics, Inc. (“Areteia”) today announces its launch as a clinical-stage biopharmaceutical company focused on putting asthma patients in better control of their disease – and back in control of their … Continued

Yieldstreet Unveils High-End-Art Fund for Smaller Investors

Investment in YieldStreet’s art fund for smaller investors starts at $10,000 with returns aimed at 15% to 17%. Asset-investment firm Yieldstreet on Friday launched the Art Equity Platform, which is a series of funds that enable retail investors to buy into a … Continued

Kaleo Launches Predictive Knowledge Sharing for Business

EL SEGUNDO, CA –(Marketwired – May 12, 2016) – Kaleo, the leading knowledge sharing solutions company, today announced updates to their Predictive Knowledge Sharing application. Kaleo is the first and only application on the market that connects employees with internal experts and … Continued

YieldStreet: REVAMPING A BROKEN INVESTMENT PROCESS

Traditionally, investors have looked to equities, bonds, and cash instruments as places to invest their money, but resulting yield from these options is low. As an entrepreneur and accredited investor, Milind Mehere was frustrated by the lack of options outside … Continued

Takei Omaze Contest

A new Omaze contest offer the winner the chance to see George Takei’s Allegiance, currently running on Broadway, and to have dinner with George and Brad Takei. The entry cost is a $10.00 donation. This donation will go to Inspire … Continued